SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-24-002393
Filing Date
2024-08-02
Accepted
2024-08-02 16:31:33
Documents
14
Period of Report
2024-07-31
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K zk2431764.htm   iXBRL 8-K 69533
  Complete submission text file 0001178913-24-002393.txt   251007

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA entx-20240731.xsd EX-101.SCH 4676
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20240731_def.xml EX-101.DEF 17919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20240731_lab.xml EX-101.LAB 27305
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20240731_pre.xml EX-101.PRE 20104
17 EXTRACTED XBRL INSTANCE DOCUMENT zk2431764_htm.xml XML 6720
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 241171520
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)